During embryonic development, cells undertake a series of cell fate decisions to form a complete organism, epitomising a branching process. In some instances, these decisions are reversible, particularly during the onset of disease. Single cell transcriptomics provides a rich resource to explore the temporal progression of bifurcations in gene activity and are therefore useful for elucidating the mechanisms of cell fate decisions, provided that the cells can be suitably ordered over a developmental axis. Most methods for inferring this ordering have been developed for heterogeneous populations of cells collected at single time points, with few approaches specifically designed with structured data in mind, such as single cell time-series data. Recent advances based on Gaussian process latent variable models (GPLVMs) address this by allowing the incorporation of prior information, such as capture time, to yield more accurate ordering of cells. However, such approaches do not allow the ordering of cells over developmental processes with more than one branch. Here we develop a pseudotime approach that allows the ordering of cells over developmental trajectories with arbitrary numbers of branches, in the form of branch-recombinant Gaussian process latent variable models (B-RGPLVM). We use first demonstrate the advantage of our approach compared to existing pseudotime algorithms. Subsequently, we use B-RGPLVMs to infer cell ordering that occurs during early human development as primordial germ cells (PGCs), the precursors of sperm and egg, and somatic cells diverge in the developing embryo. Using our approach, we identify known master regulators of human PGC development, and predict roles for a variety of signalling pathways, as well as transcription factors and epigenetic modifiers. By concentrating on the earliest branched signalling events, we identified an antagonistic role for FGF receptor (FGFR) signalling pathway in the acquisition of competence for human PGC fate. We experimentally validate our predictions using pharmacological blocking of FGFR or its downstream effectors (MEK, PI3K and JAK), and demonstrate enhanced competency for PGC fate in vitro. Thus, B-RGPLVMs represent a powerful and flexible data-driven approach for dissecting the temporal dynamics of cell fate decisions, providing unique insights into the mechanisms of early embryogenesis. Software is available from: https://github.com/cap76/BranchingGPs
Introduction
During embryogenesis, individual cells undertake a series of cell fate decision to form a complete embryo comprised of myriad cell types.
Each cell fate decision can be thought of in terms of a bifurcation , with the expression levels of key marker genes diverging between the two cell fates, epitomising a branching process. Reciprocal behaviour is encountered in recombination processes, where two or more statistical processes converge, such as when two or more cell types share a common terminal fate. A key challenge is to infer the mechanisms and inductive signals of these decision-making processes by identifying the ordering of branching events. A striking example of transcriptional branching occurs in early human development, when the inner cell mass (ICM) of the blastocyst segregates into hypoblast and epiblast, with the latter subsequently differentiating into ectoderm, mesoderm, and endoderm during the process of gastrulation (Irie, Tang, and Azim Surani 2014) . At around this time, circa weeks 2-3 in humans, primordial germ cells (PGC), the embryonic precursors of gametes, are also specified . Later, at weeks 5-6, specified PGCs undergo comprehensive epigenetic reprogramming that includes almost complete erasure of DNA methylation marks throughout the genome, save for a few escapee regions Tang et al. 2015; Gkountela et al. 2015) . During this period, PGCs also proliferate and migrate towards the genital ridges where, after colonising the gonads, they begin sexually dimorphic programs of gametogenesis. As precursors to the germline, PGCs are ultimately responsible for passing on genetic and epigenetic information to the next generation, so understand-ing the mechanisms of their specification and development is of significant practical use. Current models, based on studies in mouse and pig embryos, suggest that two signalling pathways cooperate to allow PGC fate: WNT signalling renders epiblast cells competent to respond to BMP2/4 resulting in the specification of a founder PGC population in the posterior epiblast (Ohinata et al. 2009; Aramaki et al. 2013; . While mouse PGC development has been reasonably well characterised, the specification and development of human PGCs remains only partially understood, primarily due to inaccessibility of early human embryos.
Crucially, recent studies have shown that SOX17 and PRDM1 are key regulators of PGC fate in humans Tang et al. 2015) , making their specification distinct from that in mice, which involves the combined action of Prdm1, Prdm14, and Tfap2c (Magnusdottir et al. 2013; Nakaki et al. 2013 ). Due to these differences, along with notable divergence in embryo morphology (Irie, Tang, and Azim Surani 2014) , in vitro derivation of human PGC-like cells (PGCLCs) from human pluripotent stem cells has emerged as a model to examine the earliest mechanisms regulating hPGC development (Sasaki et al. 2015a; . Interestingly, human ESCs in conventional cultures have low competence to form PGCLCs, but hESCs grown in a specially formulated "competent" medium gain competence for PGC fate and respond to BMP signalling giving rise to PGCLCs that presumably resemble premigratory in vivo PGCs .
Despite recent advances in understanding of PGC development Tang et al. 2015) , the mechanisms allowing human PGC competence acquisition remain poorly understood. Single cell RNA-seq (scRNA-seq) datasets provide unique opportunities to dissect the dynamics of cell fate decisions. In the past scRNA-seq datasets tended to be of low temporal resolution, albeit with observations in many cells, which reflect a continuum of developmental states provided the cells can be appropriately ordered Petropoulos et al. 2016; Borensztein et al. 2017; Huang et al. 2017) . Most approaches for pseudotemporal ordering of scRNA-seq datasets rely on manifold learning: that is, a preliminary dimensionality reduction, with cells ordered over the reduced dimensional space, typically by utilising curve fitting or graph-theoretic approaches . Such approaches, however, do not generally account for uncertainty in the ordering. Nor do these approaches typically provide an easily interpretable relationship between the inferred pseudotime and chronological time.
The latter effect is compounded when inferring pseudotime for datasets with multiple branches: if one branch has fewer observations, or else a period of quiescence, the branch will often be artificially truncated compared to others. This truncation can be undesirable when investigating complex developmental programs, where signalling from adjacent tissues can influence cell fate decisions, and is necessary to place branches on consistent pseudotime frames. Finally, due to decreased costs, scRNA-seq datasets are now routinely generated over more finely resolved time series, including early stages of development Petropoulos et al. 2016; Borensztein et al. 2017; Huang et al. 2017 ) and PGC development Li et al. 2017 ). The individual populations of cells associated with different stages may still reflect a continuum of states, with some degree of overlap between stages; nevertheless, the capture time should be highly informative about the ordering of cells. To address these various limitations, further methodological developments are required to extract the maximal amount of information from such data.
Nonparametric Bayesian approaches based on Gaussian process (GP) regression , would therefore be advantageous, providing a flexible framework that better reflects the underlying generative models, and are able to quantify a broad range of dynamic behaviour with minimal need for parametrization. GP-based models provide robust treatments of uncertainty, and can gracefully cope with missing observations, for example the absence of intermediate cell types.
Recent developments by have demonstrated how cells can be ordered along a single developmental axis using Gaussian process latent variable models (GPLVMs) by placing informative priors over pseudotimes. This can be thought of as a dimensionality reduction technique with one latent dimension, pseudotime, that is a priori centered on the capture time. Until recently, however, GPs could not be used to model branching processes, and these methods were thus inapplicable to developmental trajectories with more than one branch.
Recent developments by and Penfold et al., (2018, submitted) , have developed explicit branching Gaussian process frameworks (B-RGPs). Here we use a branching covariance function within a GPLVM (B-RGPLVM) to dissect the transcriptional program and signalling pathways implicated in human PGC competence and specification using scRNA-seq data from PGCs, somatic tissues, preimplantation embryos, and human embryonic stem cells (hESCs). By adopting an integrative analysis of branching and recombination between PGC and somatic lineages, as well as between in vivo and in vitro datasets, we correctly identified known PGC genes and putative regulators. Analysis of the earliest branching events highlighted possible roles for FGF receptor (FGFR) signalling in the acquisition of competence for human PGC fate, which was experimentally validated using human in vitro models of PGC specification. Indeed, pharmacological blocking of FGFR or its downstream effectors (MEK, PI3K and JAK) enhanced the competency for PGC fate in vitro. Thus, our approach can inform genetic and signalling perturbations for cell fate decisions.
Methods
The ability to leverage capture time and other prior information, as well as the ability to quantify uncertainty in pseudotemporal ordering is particularly important given the inherent limitations of pseudotime approaches (see e.g., discussion in Campbell and Yau (2015) ; Weinreb et al. (2017) ). Our model assumes we have cells that have been assayed at one of < distinct known capture times % = ( ) , … , , ). The aim is to infer a corresponding set of pseudotimes, . = ( ) , … , , ), such that the gene expression profiles are smooth and reflect the general developmental trajectory of the process. Within the GPLVM model of , the pseudotimes, are assigned a prior that is conditioned on the capture times, % , that is Gaussian distributed: . | % ∼ ( % , 6 ). The GPLVM model assigns an independent Gaussian process prior to the expression profile change-point kernel ) with branch time \ and slope parameter . Here and ′ are branch labels that correspond to . , .
@ ;
h,6 is the Dirac delta function that is 1 if and only if = 2. Finally, ) is the kernel for branch 1 and 6 is the kernel that models the deviation of branch 2 from branch 1.
or cells sampled from a bifurcating developmental process with capture times, % = ( ) , … , , ), and branch-labels, % = ( ) , … , , ), each gene can thus be assigned an independent B-RGP prior over the pseudotimes, and the composite likelihood is:
where 9 is the vetctor of gene expression for the th gene. We may easily sample from this using Markov chain Monte Carlo.
Results
To assess the ability of B-RGPLVMs to pseudotemporally order data over a branching process, we first benchmarked using microarray time series data measuring the Arabidopsis thaliana transcriptional response to the necrotrophic bacteria Botrytis cinerea ; GEO GSE39597). This dataset consists of two time-series: (i) an infection time-series showing changes in gene expression in Arabidopsis at two hour intervals over a 48h period after inoculation with B. cinerea; and (ii) a time-matched control time series. In general, we note that BRGPLVMs outperforms existing approaches for pseudotime ordering (compare Supplementary Figures 1 and 2 ; for full details see Supplementary Section 1). Accuracy of the models increases as the number of marker genes increases. For the case = 40, 4 out of 5 replicates were nearly perfectly ordered for both the infected and control time series, and no obvious improvements seen for = 80. Consequently, when pseudotemporally ordering data, we used >40 genes.
Transcriptional branching and recombination in PGCs
Early human PGC development remains underexplored, since the use of human embryos at the time of PGC specification is limited by ethical and practical considerations. On the other hand, differences between human and rodent development have necessitated the use of human-specific model systems (Irie, Tang, and Azim Surani 2014 ). One such model relies on derivation of PGC-like cells (PGCLCs) from human pluripotent stem cells (hPSCs) in vitro Sasaki et al. 2015b) ; for this, conventional hPSCs are first placed in appropriate media to gain germline competence and then exposed to BMP signalling to form
PGCLCs. An added advantage of this system is the ability to use genetic and pharmacological tools to address the roles of particular regulators in human PGC fate. Unbiased approaches involve genetic and chemical screens, which tend to be costly and time-consuming. As a consequence, statistical approaches are required to correctly leverage multiple in vivo and in vitro datasets to identify priority targets for more focused experiments. Here we have used B-RGPLVMs to infer the transcriptional branching dynamics of early human PGCs to identify the earliest regulators of PGC fate. For this we used scRNA-seq data from hPGCs and age-matched neighbouring somatic tissues from weeks 4 through to 19 ; GEO GSE63818), as well as pre-implantation embryos (oocytes, zygotes, two-cell, four-cell, morula and blastocyst-stage cells), and conventional hESCs at passages 0 and 10 ; GEO GSE36552). A summary of the various cell types is included in Table 1 .
Together, these datasets allow investigation of the dynamics of decision making in early human embryos, as cells undergo specification towards the germline, and provide a rich testbed for addressing the differences between the in vivo dynamics of PGC development, and the inferred dynamics of pseudotemporally ordered hESCs recombining with Wk4
PGCs. Whilst there is currently no single-cell transcriptomic data available for PGC-competent hESCs and PGCLCs, the ability of GPs to cope with missing and unevenly sampled data should allow useful insights to be extracted from conventional hESC and in vivo hPGC data.
Benchmarking of B-RGPLVMs
To separate out the developmental trajectories of PGCs from those of gonadal somatic cells we ordered single cells along a two-component
Matérn branching process using a Gaussian process latent variable model (GPLVM; Lawrence (2003 Lawrence ( , 2005 ) with informative priors placed over the pseudotimes centered on the cells' developmental stages . Preliminary benchmarking of branch-recombinant GPLVMs (B-RGPLVM) using other datasets suggested that cells could be accurately (pseudo-temporally) ordered along a branching process using around 40 genes, and we therefore used the expression of 44 marker genes identified in , which included PGC, pluripotency, mesoderm, and endoderm markers.
For comparison purposes we also pseudotemporally ordered cells using previously established methods, including Monocle2 , TSCAN . We also compared to a variety of other approaches including Wishbone , SCUBA , and SLICER , and evaluated the accuracy of these methods by comparing the correlation between the inferred pseudotime, and the capture time (Supplementary Figure 3) .
Overall, the B-RGPLVM offered the best performance, with Pearson' correlation of 0.972 for the PGC branch and 0.966 for the soma branch.
Other approaches also performed well. For example, Monocle2 correlated well when the PGC branch and soma branches were considered separately, with correlation 0.894 and 0.922 for the PGC and soma branches respectively, although accuracy was degraded when both branches were considered together. TSCAN had a Pearson's correlation of 0.8534 and 0.918. All other approaches showed a general ability to separate out preimplantation cells from PGC or soma, and showed correlation >0.7 for both branches. A major difference between previous approaches and our B-RGPLVM is the ability to place the different branches on a similar time frame. Only B-RGPLVMs and Monocle2 appeared to show any degree of alignment between the branches, with B-RGPLVM performing better overall (Supplementary Figure 3) . Benchmarking against most widely used methods revealed that B-RGPLVM is better suited for pseudotime ordering of cells along multiple branches and places the cells closer to their real capture time.
We further evaluated the accuracy of our B-RGPLVM using unlabelled data, assuming that the branch-label and capture-times for hESC and blastocyst cells were unknown variables to be inferred within the algo- (Figure 1(a) ). Furthermore, whilst hESCs are derived from the ICM of blastocysts, our approach placed them between day 6 blastocysts and Wk4 cells (PGCs and soma), albeit with some degree of overlap. This suggests that hESCs cultured under these conditions are developmentally more advanced than cells of the ICM, consistent with conventional hESCs sharing characteristics with the post-implantation epiblast ; Figure 1 (a), inset). Finally, it is also worth noting that our inference assigned later pseudotimes to hESCs at passage 10 compared to passage 0 (p<0.05, two-sided t-test; Figure 1(b) ), potentially reflecting culture-induced adaptations.
Inferring branching structure on a genome scale
Once we had established a point estimate for the pseudotemporal order of cells using the chosen set of 44 marker genes, we used B-RGPs to identify complex patterns of branching present on a genome scale. Note that to do so, we fixed pseudotimes according to the ordering at step 30,000 in our earlier pseudotime analysis, and the results of this section do not take advantage of the uncertainty over the pseudotimes. For each gene, performing B-RGP regression (Penfold et al., 2018, submitted) by fitting one of three models and using the BIC to select the optimal structure. The three models are as follows: (i) 
In vivo dynamics of human PGC development.
Using B-RGPs we identified genes that branched between hPGCs and human somatic cells. In total, 3,930 genes were identified as being upregulated in hPGCs versus soma, with 1,355 down-regulated. It is likely that these genes are involved in a broad range of biological processes, including the acquisition of competence for PGC fate, PGC specification and maintenance, as well as epigenetic reprogramming, migration, and gametogenesis. We therefore performed a preliminary GO and KEGG pathway analysis using a permissive p-value (p<0.1, hypergeometric test), with the aim of identifying biological processes that branched early in development. We subsequently ordered terms according to when 50% of their associated genes had branched, as in , with a heatmap representation of this temporal progression shown in Supplementary Figure 5 (see also associated Supplementary (Lawson et al. 1999; Ohinata et al. 2009; De Felici 2013; Leitch, Tang, and Surani 2013; .
A histogram of the time of branching between PGCs and soma ( Figure   1 (c)) shows a multi-modal distribution, with most responses occurring after blastocyst-stage, but prior to week 4, consistent with the expected timing for PGC specification at around weeks 2-3 of development (see e.g., Tang et al. (2016) ). Importantly, two key regulators of human PGC fate, SOX17 and PRDM1 , were shown to branch early in the pseudotime series, prior to late PGC markers such as DAZL (see Figure 1 (d, e, f)). In addition to regulating human, but not mouse, PGC fate, SOX17 is a known endoderm TF in mice and humans (KanaiAzuma et al. 2002; . It is therefore possible that a subset of its target genes are shared between human endoderm and PGC lineages. To test this, we looked at genes that were differentially expressed in hESCs following overexpression of SOX17 compared to parental hESC lines GSE10809) . Genes that branched between PGCs and soma were statistically enriched for genes that were differentially expressed in response to SOX17 overexpression (p<1x10 -35 , hypergeometric test using Enrichr). Reanalysis of this microarray data showed that common genes included the PGC regulator PRDM1, known to act downstream of SOX17 . Crucially, the overlapping targets of SOX17 were, themselves, shown to branch earlier than average branching times in the dataset as a whole (p<1x10 -7 , KolmogorovSmirnov test), and earlier then testosterone signalling, involved in later male germ cell development (Figure 1(h) ). Together, these results highlight the crucial early role for SOX17 in hPGC fate decision.
To reveal additional regulatory mechanisms that could be contributing to PGC specification and maintenance, we used Enrichr Kuleshov et al. 2016 ) to find transcriptional signatures present within our set of branched genes, and used a Kolmogorov-Smirnov (KS) test to identify genes branching significantly earlier than average branching times in the dataset. That is, we looked for early and statistically significant overlaps between genes that branched (PGCs versus soma) and those that were up-regulated or down-regulated in the literature in a variety of species and cell types following knockout or overexpression studies, or upon treatment with hormones, growth factors or cytokines.
Although none of the Enrichr perturbations were performed directly in PGCs, and results might therefore be contextually very different to our system, the presence of an early and statistically robust transcriptional signature is worthy of further investigation. Furthermore, we envisage that in this way it may be possible to identify signalling molecules secreted from surrounding tissues and therefore not branching in the examined transciptome itself.
In agreement with the early branching of genes with BMP-related GO/KEGG terms around the time of PGC specification, comparison with the Enrichr database showed a strong overlap of branched genes with those differentially expressed in hESCs following treatment with BMP4
(p<5x10 -40 , Enrichr). The identified targets of BMP4 branched early in the pseudotime series compared to branch times overall (p<5x10 -4 , KStest; Figure 1 (h)), reflecting the known role of BMP4 as a PGC-inductive signal (Lawson et al. 1999 (Hens et al. 2009) , and has been implicated in the emergence of germ cell cancers (Sandberg, Meloni, and Suijkerbuijk 1996; Mostert et al. 1998 (p<1x10 -6 , Enrichr; NS, KS-test), which contribute to PGC DNA demethylation via conversion of the modified genomic base 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) (Ito et al. 2010) . In general, genes associated with perturbations of epigenetic and chromatin modifiers appeared to branch later than genes associated with perturbations of WNT and BMP signalling, in line with existing experimental evidence . Amongst the related enriched GO terms, we noted several related to cAMP activity, consistent with recent studies in mice identifying the roles of cAMP signalling in mouse PGC proliferation and epigenetic reprogramming (Ohta et al. 2017 ).
In addition to picking up known PGC regulators, we were also able to identify other pathways potentially involved in human PGC fate, including a putative role for tumour necrosis factor (TNF) signalling in PGC development, based on the enrichment of KEGG term 'TNF signalling pathway', and the TNF transcriptional signature (p<5x10 -13 , Enrichr;
p<0.05, KS-test). Targets of TNF were shown to branch later than BMP4/SOX17-responsive genes, and around the same time as genes that branched in response to perturbations of TET1, TET2, and TET3 ( Figure   1 (i)). This places the timing of TNF-signalling roughly in concordance with epigenetic reprogramming in proliferating, migratory PGCs. Although TNFA has roles in apoptosis, previous studies in mouse models suggest it can stimulate proliferation of pre-gonadal PGCs in culture (Kawase et al. 1994; Makoolati, Movahedin, and ForouzandehMoghadam 2016) . Whilst TNF, itself, was not identified amongst the branched genes, and its expression appears to be generally low in PGCs , one of its receptors, TNFRSF1A, was found to be branched, and we cannot exclude that TNF is secreted from surrounding tissues. Indeed, TNFA is expressed in Schwann cells (Wagner and Myers 1996) , and TNF signalling might therefore support PGCs proliferation and survival as they migrate along the nerve fibres to the genital ridges (Mollgard et al. 2010) .
Differences between inferred in vivo and in vitro dynamics of human development
Current knowledge of human germ cell specification is largely informed by in vitro PGCLC derivation from hESCs. While it is challenging to directly validate these findings in vivo, we reasoned that we could highlight the most relevant processes by comparing the inferred dynamics of PGC induction in early embryos versus pseudotemporally ordered hESCs. In particular, the ability to derive human PGC-like cells (PGCLCs) from hESCs in vitro prompted us to regard hESC to PGC transition as a recombination process. The comparison of PGCLC transcriptome with that of in vivo PGCs suggests that PGCLCs closely resemble pre-migratory PGCs . We therefore considered the recombination to occur between hESC and the earliest available PGC dataset (Wk4). Thus, the comparison of hESC and hPGC dynamics represents a branch-recombinant process, whereby specified hPGCs and hESCs branch from a common precursor (blastocyst), with hESCs dynamics allowed to recombine with W4 hPGCs upon exposure to appropriate stimuli.
This analysis identified 1,331 branching genes, which were up-regulated in hESCs compared to in vivo. The timing of divergence between inferred in vivo and in vitro dynamics is shown in Supplementary Figure   4 (c). GO analysis of these groups identified a number of enriched terms, including those relating to cell adhesion, response to hormones, and, importantly, response to BMP4 and WNT, as well as terms relating to germ cell development and meiosis (see Supplementary Table 2 ).
Amongst the most highly enriched transcriptional signatures was the overexpression of SOX17 (p<1x10 -13 , Enrichr), a critical regulator of PGC fate. PRDM1, another key regulator of PGC fate, was not identified amongst the enriched lists due to a lack of human PRDM1 perturbations in the Enrichr database; however de novo motif analysis using DREME (Bailey 2011) on 1kb windows upstream of the TSS identified two motifs (p<1x10 -17 , p<5x10 -7 ) resembling that of human PRDM1 (p<0.01, p<5x10 -3 , TOMTOM, Gupta et al. (2007) ). Manual comparison against bulk RNA-seq data of PRDM1-overexpressing cells ) showed a significant overlap (p<5x10 -24 , hypergeometric test).
Together these results highlight the importance of SOX17/PRDM1 in the specification of hPGCLCs from hESCs, with recent studies demonstrating that the concomitant overexpression of SOX17 and PRDM1 expression in hESCs is sufficient to drive PGCLC fate, even in the absence of cytokines .
Pseudotime ordering identifies regulators of early germ cell development
A strong signature was also noted for KIT (p<1x10 -6 , Enrichr), potentially highlighting an important role of its ligand, SCF, in PGC cell fate.
SCF has been implicated in PGC proliferation and migration (Hoyer, Byskov, and Mollgard 2005; Mollgard et al. 2010) and is added as to the in vitro culture medium used to derive PGCLCs from hESCs . Although KITLG is not expressed in hPGCs or hPGCLCs , the expression of KIT is significantly upregulated in hPGCs, and SCF (encoded by KITLG) is potentially secreted from adjacent cells. Indeed SCF is expressed in Schwann cells (Mollgard et al. 2010) , as well as Sertoli and Leydig cells (Sandlow et al. 1996) .
De novo motif analysis using DREME further identified several SOX motifs, and the most highly enriched transcriptional signature from Enrichr was for SOX2 knockout (p<5x10 -23 ). SOX2 is a core pluripotency factor in mouse and human, and is also involved in neural ectodermal differentiation (Masui et al. 2007; Fong, Hohenstein, and Donovan 2008; Thomson et al. 2011) . Interestingly, while it is required for mouse PGC fate (Campolo et al. 2013) , it is suppressed in human PGCs and PGCLCs . Thus, using our approach, we are able to pick up human-specific PGC transcriptional signatures.
The enrichment of a SOX2 KO signature may indirectly reflect the upregulation of PRDM1, a known repressor of SOX2 (Lin et al. 2014) .
However, recent studies have highlighted the importance of the switch between SOX2/OCT4 to SOX17/OCT4 in mouse endodermal specification (Aksoy et al. 2013) , and the strong signature identified here points to the importance of correctly regulating SOX2/SOX17 in PGC development. It is therefore possible that timely SOX2 downregulation allows SOX17-driven PGC specification. Indeed, overexpression of SOX2 in hESCs under conditions favouring germline differentiation skewed cell fate towards neural lineages (Lin et al. 2014) , suggesting a potential competition between SOX2 and SOX17 in this context. inhibited by the fourth inhibitor in 4i hESCs (SP).
Early branching identifies key regulators of competence for PGC fate
In order to experimentally test the involvement of these signalling pathways in PGC competence, we compared PGCLC induction efficiencies from hESCs cultured in either complete competent (4i) medium (control) or lacking one of the 4 inhibitors: (i) "4i-CH" (4i without GSK3B inhibitor); (ii) "4i-PD03" (4i without MEK inhibitor); (iii) "4i-SB" (4i without p38 inhibitor), and (iv) "4i-SP" (4i without JNK inhibitor). hESCs were cultured in these alternate media for at least one passage and collected for standard PGCLC differentiation (as in ). PGCLC induction efficiency was then quantified by flow cytometry (Figure 2 ).
This was facilitated by the use of PGC-specific knockin reporter cell line NANOS3-tdTomato (N3tdTom; ) and staining for PGC surface markers AP and CD38 . This identified that while removal of CH (GSK3βi) and SP (JNKi) from 4i did not significantly change PGCLC competence, withdrawal of PD03 (MEKi) and SB (p38i) strongly reduced the propensity of hESCs to form PGCLCs (Figure 3(a) ), consistent with a predicted role for MEK and p38
but not JNK signalling in conferring PGC competence. Considering the crucial role of WNT signalling for PGC competence in mice (Ohinata et al. 2009; Aramaki et al. 2013) , it was surprising that CH (WNT agonist, Ying et al. (2008) ) withdrawal did not impact on PGCLC competence.
We hypothesized that 4i hESCs might produce WNT in an autocrine fashion. Indeed, the number of PGCLCs generated from hESCs grown with WNT pathway inhibitor IWR-1 (IWR, Chen et al. (2009) ) either in the presence or the absence of CH, was reduced compared to the control (Figure 3(b) ).
Notably, "4i-CH" and "4i-SB" cultures deteriorated at later (>4) passages, reflecting the importance of these inhibitors to sustain self-renewal of 4i hESCs (Gafni et al. 2013 ). In particular, low competency observed upon withdrawal of SB (p38i) The most drastic effect on PGCLC competence was observed upon withdrawal of MEK inhibitor, PD03, with a strong reduction in the induction of PGCLC (Figure 4 (b)), although unlike "4i-CH" or "4i-SB", "4i-PD03" cells could be maintained for many passages (>20). Importantly, the defect of "4i-PD03" hESCs to differentiate to PGCLCs could be rescued (within one passage) if PD03 was reintroduced (Figure 4(c) ).
Since our analysis revealed early branching of an upstream component of Quantification of PGCLC induction efficiency from "4i-PD03" relative to 4i hESCs. Data are shown as mean ± SD of 9 independent experiments. **** p ≤ 0.0001, Holm-Sidak t-test (on relative frequency of N3+AP+ cells). (c) "4i-PD03" differentiation defect can be rescued by reintroducing PD03. hESCs grown in "4i-PD03" for >10 passages were transferred to complete 4i medium (with PD03) for 1 or 3 passages and subjected to PGCLC induction. Induction efficiency is shown relative to "4i-PD03"-derived PGCLCs; n=1. Here by using an explicit statistical model for branching within a GPLVM, we have a statistical model for pseudotime that is not only reflective of the generative model of cell fate decisions, but is also apt to capture important information about the system such as capture time.
Our approach is specifically designed with highly resolved single-cell RNA-seq time series in mind, and is shown to provide more accurate orering of cells compared to other approaches such as Monocle2 and TSCAN. Nonetheless, these gains require significantly more compute power, and will not, generally be as applicable for datasets with few time observations.
Having established the advantages of B-RGPLVMs we used our approach to investigate the dynamics of cell fate decision making in human primordial germ cells (hPGCs). By shortlisting genes that branched early between PGCs and soma, we correctly identified key early regulators of PGC fate, most notably SOX17, a classic endoderm marker gene that was only recently shown to play a prominent role in human PGC specification Tang et al. 2015) . Furthermore, by jointly leveraging in vivo and in vitro datasets, we were able to suggest the importance of correct suppression of SOX2 and concomitant up-regulation of SOX17 in hPGC lineage. Interestingly, mouse PGCs do not require Sox17 and instead express Sox2. Many more unexplored differences exist between mouse and human PGC transcriptomes and B-RGPs could prove useful in identifying such divergent regulators, whose roles could then be tested experimentally.
Our approach also identified a number of putative regulators for laterstage PGC development, including TNF signalling. While the TNF pathway is primarily involved in pro-inflammatory apoptotic responses, emerging evidence points to its multiple morphogenetic roles (Mathew et al. 2009 ). Our analysis suggests that genes involved in TNF signalling differentially respond after PGC specification, but prior to expression of late germ cell markers, which could suggest TNF pathway's involvement in PGC migration. Indeed, TNFα is known to control cellular shape through modulating the cytoskeleton via Rho-family GTPases (Mathew et al. 2009) Whilst we were able to correctly identify key events in the acquisition of competency and specification, key intermediate cell types were absent from both our in vivo and in vitro datasets. Notably, single cell RNA-seq for competent (4i) hESCs and PGCLCs were unavailable, although bulk RNA-seq measurements exist . A key future development will therefore aim to combine the use of single-cell and bulk RNAseq data in a principled way. Since bulk measurements represent population averages, B-RGPs would be ideally suited to this purpose, due to the ability of GPs to incorporate integral observations . A more informative approach would be single cell transcriptomic profiling of intermediate cell types, which would allow a much higher temporal resolution of the sequence of events leading to acquisition of competence and specification of hPGCs. The emergence of other in vitro models for human PGCLC derivation ) provide further opportunities for dissecting these causal regulations; by identifying differences and similarities in the dynamics of branching between different in vitro models, we could separate out the underlying biological mechanisms from culture-induced adaptations.
Better time resolution would also be crucial for predicting direct targets of key PGC regulators, such as SOX17 and BLIMP1, which could be validated by chromatin immunoprecipitation (ChIP) experiments.
Concurrent with our study, Boukouvalas, Hensman, and Rattray (2017) have built on the earlier work of , to develop Branching Gaussian processes, a probabilistic framework for the inference of bifurcations in single cell transcriptional datasets. Unlike our approach, which utilised MCMC to deal with unlabelled datasets, these branching Gaussian processes focussed on efficient, scalable (variational) approximations for a two-branch system implemented using GPflow (Matthews et al. 2016) , and were therefore similarly applicable even when cells lacked explicit branch labels. By identifying early branching events, they found known key regulators involved in the differentiation of haematopoietic stem cells into myeloid or erythroid precursors. Together with our own work, this demonstrates the usefulness of GP-based approaches for investigating complex single cell transcriptomic datasets.
In general, the use of B-RGPLVMs to reconstruct cell fate dynamics using collections of single cell RNA-seq data can be combined with traditional gene-set enrichment analyses to provide a powerful framework for elucidating the mechanisms that underpin developmental processes. Whilst differential analysis alone may be used to identify putative regulators and perturbations, the temporal resolution provided by the BRGPs significantly reduces the number of putative regulators, and concentrates on potentially key driving events, rather than enriched downstream effects (Supplementary Figure 6) . Whereas the number of identified perturbations may still remain high, future studies may be able to leverage this type of approach alongside Bayesian optimisation strategies (Ghahramani 2015) to iteratively identify optimal culture conditions and mechanisms for deriving poorly characterised cell types.
Here we focused on transcriptional branching, but our framework is equally amenable to investigate the dynamics of other branching processes, including, for example, large scale epigenetic changes that occur during development, or at the onset of disease. Indeed, recent studies have demonstrated the practicality of jointly sequencing the transcriptome and methylome from a single cell (Angermueller et al. 2016) , which should provide opportunities to fully investigate the relationship between transcriptional programs, the epigenetic state, and cell fate decisions.
Finally, the transition from pluripotency to PGC competence and ultimately to PGCs can be reversed later in development upon germ cell tumour formation, exemplifying a recombination event. Seminoma and embryonal carcinoma are two types of germ cell tumours that share similarities with PGCs and ESC, respectively (Surani 2015) , which can be distinguished using the markers identified from in vitro human PGCLC specification; seminomas and PGCs express CD38 and SOX17, while embryonal carcinomas and hESCs express SOX2 and CD30 . This underscores the importance of interrogating the transcriptional and epigenetic control of human germ cell fate and its specification from pluripotent progenitors. Ultimately, the use of B-RGPs on transcriptomics data from tumour cells could shed light on the sequence of events that lead to their formation, identify cancer markers, and guide therapeutic interventions. 
Supplementary materials to 'Nonparametric Bayesian inference of transcriptional branching and recombination identifies regulators of early germ cell development' 1 Benchmarking of branch-recombinant Gaussian process latent variable models (BRGPLVMs)
To assess our ability to pseudo-temporally order data over a branching process using B-RGPLVMs, we first benchmark using existing microarray time series data measuring the Arabidopsis thaliana transcriptional response to the necrotrophic bacteria, Botrytis cinerea ; GEO GSE39597). This dataset consists of two time-series: (i) a control time series, detailing changes in gene expression in Arabidopsis over a 48-hour period at two-hour intervals; and (ii) a time-matched infection series, in which Arabidopsis has been inoculated with B. cinerea. The infection time series has previously been used to benchmark GPLVMs for pseudo-time ordering . As outlined by , we first grouped the individual measurements into four groups containing six consecutive time points, artificially reducing the temporal resolution of each time series dataset from 24 time points to 4. We then attempted to recapture the correct ordering of cells using an increasing number of randomly selected genes within the B-RGPLVM. Here we selected 10, 20, 40, and 80 genes at random from the set of 150 previously used by . By doing so, we aimed to identify how the accuracy of the model changed with respect to increased number of gene observations, and thus empirically identify the number of genes required for accurate pseudotime ordering. We performed 5 different randomly initialised runs, with 10,000 samples in the MCMC chain, discarding the first 5,000 steps for burn-in. Run time was in the region of 10 hours, although this could be decreased using MATALBs parallel processing toolbox. Note that for each independently initialised run, a separate random selection of genes was chosen to gauge variability in the inferred ordering with respect to different genes.
Since the time series were generated using bulk microarrays, with measurements based on populations of cells, we expected a smoothly varying process, and thus for the covariance function we used a twocomponent branching covariance function composed of squared-exponential covariance functions. The hyperparameters in the model therefore corresponded to the length-scale and process variance of the base process (the control data), the length-scale and process variance of the perturbed process (the infected data), and the change point time (branch time) and branch rate for the changepoint kernel. Hyperparameters were initially fitted using maximum likelihood estimates based on the low-resolution capture times, θ ← arg A max ℒ | ] = * , . Length-scale, process-variance, and noise hyperparameters were then fixed for the remainder of the inference. For the change-point time hyperparameter, `, we assumed a univariate smoothed box prior distribution with linear decay in the log domain, , = ( − )(1 − − ), where = 1/(1 + exp (− ) ), and = 0, = 33, and = 33. Within the MCMC algorithm, we considered the following updates: 1. A Gaussian perturbation of a subset of pseudo-times. 2. A random swap of pseudotimes between adjacent data points. 3. A global swap of pseudotimes between two randomly selected data points. 4. Every 10 steps we sampled the change-point hyperparameters via HMC.
In Supplementary Figure 1 , we plot the inferred pseudo-time ordering for control and infection datasets versus the true ordering of data as the number of genes used within the GPLVM increased, with ∈ (10,20,40,80). We note that, in general, the accuracy of the models appears to increase as the number of genes increases. For the case = 40, 4 out of 5 replicates were nearly perfectly ordered for both the infected and control time series, with a mean correlation of >0.97 and >0.98 respectively over the five runs (for N=40). No obvious improvement was seen when increasing the number of marker genes to 80 (Supplementary Figure 1(c) ). Consequently, when pseudo-temporally ordering data, we used >40 genes.
For comparison purposes, we also performed pseudotime using the full list of 150 marker genes previously used by as taken from the main text of . Here we used two approaches:
• Monocle2 . We first ran Moncle2 using the combined control and treated datasets. Subsequently we ran it on the control and treated datasets separately. The later analysis showed higher correlation between inferred pseudotime and measurement time and are the results reported here.
• TSCAN . We used the online TSCAN app (https://zhiji.shinyapps.io/TSCAN) on the control and treated datasets separately. As the data was already log normalised we applied no normalisation. We used PCA for dimensionality reduction, with number of components set using the 'Automatically select optimal dimension for PCA' option. Finally the number of clusters was selected with the 'Use optimal cluster number' option, and pseudotimes exported as csv files.
In supplementary Figure 2 we plot the measurement time versus inferred pseudotime for Moncle2 and TSCAN respectively for the control and infected datasets. For TSCAN we saw Pearson correlation of 0.74 and 0.81 respectively in the control and infected datasets, whilst for Monocle2 we found a correlation of 0.85 and 0.83 respectively. For the BRGPLVM we found a mean correlation of 0.97 and 0.99 respectively over five runs (for N=40).
Single cells from pre-implantation embryos, PGCs, somatic cells and ESCs ) were initially pseudotemporally ordered over a two-component branching process using 44 marker genes. For each of the 44 genes, the trajectory for specification of PGCs was chosen to represent the base process, due to this class having the most data points, with developmental trajectories for soma representing the branch process. Pre-blastocyst stage cells were randomly assigned to either branch with equal probability, whilst branch labels for blastocyst stage cells and ESCs were inferred within the algorithm. We performed five randomly initialised runs, using 30,000 steps in the MCMC chain, taking approximately 24 hours using a single CPU, although runtime could be decreased using the MATLAB parallel computing toolbox. The order of cells at step 30,000 appeared to show good overall correlation across these five runs, with mean correlation coefficient, = 0.9768 ± 0.003.
For comparison purposes we also pseudotemporally ordered cells using a variety of other pseudotime methods, including Monocle2 , TSCAN , Wishbone , SLICER , and SCUBA . In all cases we
• Moncole2 ,. Here we ran Monocle2 several times. Initially we included all in vivo cells and attempted to capture the bifurcations between soma and PGCs. Within the algorithm, we used SOX17 and WT1 as marker genes for terminal fates of PGC and soma, respectively. In the second instance, we separated out the data, first combining pre-implantation data with PGCs, to infer the PGC trajectory, and then combining pre-implantation with soma. The greatest correlation between developmental stage and pseudotime was found for the second run i.e., running on the two branches separately.
• TSCAN . To generate pseudotimes we ran TSCAN using the online app. PCA was used for dimensionality reduction, and clusters were selected using the optimal cluster number option. Finally, we manually tuned the ordering of clusters and selected the combination that gave the greatest correlation between developmental stage and pseudotime.
• SCUBA and SLICER algorithms were run using default settings.
• Wishbone was run using the accompanying GUI, using default settings. Due to numerical issues, we ran with a reduced number of genes compared to that used for Monocle2, TSCAN, SCUBA and SLICER.
We evaluated the accuracy of the various approaches by comparing the correlation between the inferred pseudotime order and developmental stage (Supplementary Figure 2) . All methods appeared able to broadly separate out the different cells types e.g., pre-implantation, PGCs and soma, with B-RGPLVM performing best at capturing the developmental trajectory, followed by Monocle2 and TSCAN.
Supplementary Figure 3:
Comparison of pseudotime ordering using MONOCLE, TSCAN, Wishbone, SCUBA and SLICER versus B-RGPLVM. Here we indicate the inferred pseudotime (y-axis) versus the true developmental stage. All approaches appear to be able to generally separate out pre-implantation cells from either PGCs or soma, with B-RGPLVMs performing best. Together, these observations highlight the increased accuracy afforded when including prior information about capture time in B-RGPLVMs and a more realistic generative model in terms of an underlying branching process. Note that the distribution of cells from pre-implantation embryos will be identical when comparing within a method.
COMPLEX BRANCHING DURING EARLY EMBRYO DEVELOPMENT IN HUMANS
Once a point estimate for the pseudotemporal order of cells had been established, we looked for more complex branch-recombinant structures on a genome scale, by fixing pseudo-times according to the order at step 30,000 in our earlier pseudotime analysis. As the pseudotimes are fixed, this is simply a case of fitting GP model with different branch structures (B-RGP regression). Here we considered the dynamics of PGCs, somatic cells, and ESCs. Each of the three groups was randomly assigned preimplantation cells with equal probability, except for the ESCs, which partially overlapped with blastocyst stage cells; here we instead randomly assigned pre-blastocyst cells. This assignment reflects our expectation that divergence between PGCs and soma occurs post blastocyst. To capture the dynamics necessary to drive ESCs towards week 4 PGC fate, we also assigned half of the male hPGCs to the ESCs class. representing genes that showed no divergence between PGCs, soma or ESCs. Because these datasets represent single-cell measurements that might be intrinsically less smooth than the microarray datasets, we assumed a Matérn covariance function throughout. As in previous analyses, we optimised hyperparameters to their MAP values and used the BIC to select the branching structure for each gene. The frequency of the three groups is indicated in Supplementary Figure 9 (a), which shows that most genes were not differentially expressed i.e., non-branching. A histogram of the timing of branching is indicated in Supplementary Figure 9 (b, c), and shows that of the genes that diverge between PGCs and soma, most do so between blastocyst stage and week 4, as expected. Following GO analysis on the individual groups using permissive p-values (p<0.1 following multiple hypothesis test correction), we ordered terms by the pseudo-time at which 50% of their associated genes had branched, as previously done in . In Figure 16 we indicate a heatmap representation of this ordering, where the x-axis represents the pseudo-time, the y-axis represents individual GO terms, and the colour indicates the fraction of genes that had branched. From these heatmaps we can see a continuum of responses. An associated table containing the full list of terms associated with the y-axis is available in Supplementary Table 4 .
ANALYSIS OF SOX17 OVEREXPRESSION LINES
We identified differentially expressed genes in hESC lines constitutively over-expressing SOX17 ; GSE10809). Differential expression was evaluated using a Student's t-test on log2 fluorescence versus parental lines using a cut-off of p<0.03 and log2 fold change >2, similar to . 
GENE SET ENRICHMENT ANALYSIS
Gene set based enrichment analysis was used to identify significantly enriched terms using Enrichr database. Here we focused on enrichment of GO 2017 and KEGG 2016 terms using permissive pvalues (p<0.1 following multiple hypothesis testing correction). Using Enrichr we also looked for enrichment of Kinase Perturbations from GEO, Single Gene Perturbations from GEO, and Ligand Perturbations from GEO, using p-value cut-off of p<0.01 (following multiple hypothesis testing correction).
Enrichment of plant ontologies were evaluated using Plant Gene Set Enrichment Analysis (Yi, Du, and Su 2013) , for the following ontologies: Biological Process (BP), Cellular Components (CC), Molecular Function (MF), KEGG, and PlantCyc. In supplementary Table 1 we report all terms with FDR <0.05.
EXPERIMENTAL PROCEDURES

CELL CULTURE AND PGCLC DIFFERENTIATION
hESCs (WIS2-NANOS3-T2A-tdTomato (N3-tdTom, ) were cultured as in on irradiated mouse embryonic fibroblasts (MEFs) (GlobalStem) in 4i medium (Supplementary Table 5 ) or modifications therefrom (Supplementary Table 6 ). Media were replaced every day. hESCs were passaged by single-cell dissociation using 0.25% Trypsin-EDTA (GIBCO). 10 μM ROCK inhibitor (Y-27632, TOCRIS) was added for 24 hours after passaging.
To induce PGCLCs , hESCs were trypsinized, filtered and plated into ultra-low cell attachment U-bottom 96-well plates (Corning, 7007) at 4,000 cells/well density in 100 μl PGCLC medium (Supplementary Table 7) The plate was centrifuged at 300g for 3 minutes and placed into a 37 °C 5% CO 2 incubator until embryoid body (EB) collection for downstream analysis. Reporter fluorescence intensities were monitored daily throughout differentiation using Olympus IX71 microscope.
Supplementary Tables 1-4 are available as separate spreadsheets. Supplementary Table 6 . Modifications of the 4i medium used in the competence screen.
Supplementary
Medium Recipe
4i-PD03 4i as in Supp. Table 5 without PD0325901  4i+PD17 4i as in Supp. Table 5 supplemented with indicated concentrations of PD173074 (TOCRIS bioscience) 4i-PD03+PD17 4i-PD as above supplemented with indicated concentrations of PD173074 (TOCRIS bioscience) 4i+LY 4i as in Supp. Table 5 supplemented with 10 μM LY294002 (Sigma) 4i-PD+LY 4i-PD as above supplemented with 10 μM LY294002 (Sigma) 4i+IWR 4i as in Supp. Table 5 supplemented with 2.5 μM IWR-1 (Sigma) 4i-CH 4i as in Supp. Table 5 without CHIR99021 4i-CH+IWR 4i as in Supp. Table 5 without CHIR99021 supplemented with 2.5 μM IWR-1 (Sigma) 4i-SB 4i as in Supp. Table 5 without SB203580 4i-SP 4i as in Supp. Table 5 without SP600125 4i-LIF 4i as in Supp. 
Flow Cytometry
D4 or D5 EBs were washed in PBS and dissociated with 0.25% Trypsin-EDTA for 15 min at 37°C. Cells were resuspended in FACS buffer (3% FBS in PBS) and incubated with antibodies specified in Supplementary Table 8 . After washing with FACS buffer, the cells were recorded on BD LSR Fortessa. Data were analysed using FlowJo (Tree Star).
Supplementary Table 8. Antibodies used for flow cytometry Name Dilution Manufacturer
Alkaline Phosphatase PerCP-Cy5.5 #561508 2.5 μl/assay BD Pharmingen Alkaline Phosphatase AF647 #561500 2.5 μl/assay BD Pharmingen CD38 PerCP-Cy5.5 #303522 2.5 μl/assay BioLegend CD38 AF647 #303514 2.5 μl/assay BioLegend
Real-Time Quantitative RT-PCR
Total RNA was extracted from unsorted hESCs using RNeasy Mini Kit (QIAGEN). cDNA was synthesized using QuantiTect Reverse Transcription Kit (QIAGEN). qPCR was performed on a QuantStudio 12K Flex Real-Time PCR machine (Applied Biosystems) using SYBR Green JumpStart Taq ReadyMix (Sigma) and human-specific primers (Supplementary Table 9 ). The ΔΔCt method was used for quantification of gene expression. Three technical replicates were used for each biological replicate.
Dominant-negative ERK expression
For inducible expression of dominant-negative ERK1 (DN-ERK), a cDNA from pFLAG-CMVhErk1(K71R) (Addgene plasmid #49329) encoding human ERK1 with K71R mutation (Robbins et al. 1993) was cloned (into a doxycycline (dox)-inducible PB-TRE-3G vector to yield pPB-TRE-3G-DN-ERK-IRES-EGFP. The plasmid was generated using In-Fusion cloning (Clontech) according to manufacturer's recommendations. Primers used for cloning are specified in Table 6 . N3tdTom hESCs were co-lipofected with 2 μg PB-TRE-3G-DN-ERK-IRES-EGFP, 2.5 μg PBase and 0.5 μg pPBTET3G-Neo . Lipofection was performed using OptiMEM (GIBCO) and Lipofectamin 2000 (Invitrogen) according to manufacturer's recommendations. 
Supplementary
Introduction
A common class of behaviour encountered in the biological sciences involves branching. In a branching process, often driven by a biological perturbation, a statistical process bifurcates at a specific time, leading to two potentially correlated processes that may, themselves, undergo further branching . Reciprocal behaviour is encountered in recombination processes, where two or more statistical processes converge. Such branching and recombination are frequently encountered in transcriptional time series datasets involving host--pathogen interactions. The initial response to infection is the activation of innate immunity, a highly--conserved response based upon perception of non--self. Subsequently, pathogens can deliver protein effectors which collectively suppress immunity, and later collaborate to reconfigure plant metabolism for pathogen nutrition. Thus, initially, the expression dynamics of key infection marker genes will be identically distributed in both infected and uninfected host cells. Expression patterns will begin to diverge as the host mounts immunity; in many cases, this innate immune response is suppressed by the pathogen, potentially driving expression levels of certain genes back to uninfected levels. Indeed nearly 50% of the transcriptome is observed to be differentially expressed during some plant infections . More complex patterns of branching and recombination may exist in such datasets due to the ongoing evolutionary arms race between pathogens and their hosts (Jones and Dangl 2006; Boller and He 2009) . The inference of branching and recombination processes from systems level measurements, such as collections of microarray or RNA--sequencing data, remains a difficult challenge, partially due to datasets being noisy in nature, with (potentially) missing observations or uneven temporal sampling. The dynamic nature of different biological systems may also vary significantly, frustrating efforts to find a robust, broadly applicable approach to the inference of branching and recombination. Nonparametric Bayesian approaches to inference would therefore be advantageous, addressing these key issues. Gaussian processes represent a flexible nonparametric Bayesian approach to nonlinear regression able to gracefully cope with uncertainty, uneven sampling and a diverse range of dynamic behaviour . However, currently, Gaussian processes treatments for branching processes have only been developed for the two--branch case Stegle et al. 2010 ). Here we develop an approach to inference for arbitrarily complex branching and recombination processes, in the form of branch--recombinant Gaussian processes (B--RGPs). In Section 2 we first introduce B--RGPs, highlighting their key limiting behaviour. In Section 3 we demonstrate the advantages of B--RGPs over GPs on a variety of simulated datasets, and in Section 4 we demonstrate the utility of our approach on genome--scale time--course microarray data by identifying transcriptional branching and recombination in Arabidopsis thaliana infected with bacterial pathogen Pseudomonas syringae. Finally, in Section 5, we discuss a variety of possible applications for B--RGPs and future avenues for research.
Methods
Within a Bayesian setting, Gaussian processes (GPs) can be used to represent prior distributions over smooth functions, providing a flexible framework for regression and classification with robust treatment of uncertainty . This makes GP--based approaches ideal frameworks for quantifying the dynamics of gene expression from biological observations (Stegle et al. 2010; Kalaitzis and Lawrence 2011; Breeze et al. 2011; . For regression, we typically have a set of observations, , assumed to be noisy instances of a continuous underlying function at input locations : = + , where ε represents Gaussian additive noise. In our applications, will typically be used to denote a vector of the observed expression levels for a given gene at times, . We can assign the unknown function a GP prior, denoted ( , ( , ′)), and analytically evaluate the posterior distribution at a set of new input locations, * . The marginal likelihood, too, may be analytically evaluated, making GPs a flexible and efficient framework for both prediction and model comparison. Previous GP--based approaches to branching have been outlined for the two--dataset case i.e., where there exists two biological processes following branching. These include the studies by Stegle et al. (2010) , who developed a GP two--sample approach, based on mixtures of GPs, and the more recent work of , who demonstrate explicitly how a two--branch process can be encoded within a joint GP model using squared--exponential and Matérn covariance functions. To our knowledge, the generalisation of GPs to more than two branches has not been addressed to date. Furthermore, whilst the mixture model of Stegle et al. (2010) allows for recombination, it relied on sampling based inference, and no explicit closed--form solution to recombination has been outlined. A useful extension to the GP framework is the multiple output hierarchical Gaussian process (HGP; ), in which a basal process is defined by a zero--mean GP with covariance function } ( , $ ), with a subsequent process having mean } ( ) and covariance function, < ( , $ ):
Within this framework, we assume noisy observations of the functions, } = } + , and < = < + , and may analytically evaluate the posterior distribution at a new set of input locations for prediction, or the marginal likelihood for model comparison. More general models, involving multiple layers of hierarchy, can easily be encoded using HGPs. A class of branching behaviour can naturally be encoded within this HGP framework, assuming the basal (main branch) process is defined by a zero--mean GP with covariance function `•( , $ ), with a subsequent process having mean `•( ) and an appropriate covariance function that ensures the two processes are identically distributed prior to an arbitrarily chosen time point, `:
where 2 = 2 , $ denotes a zero--kernel, and / 0 ( } , < ) denotes a change--point kernel ), defined as:
where 1 − = 1 + tanh / 0 ƒ/ 1 /2. Here we introduce two hyperparameters: `, which represents the branch time, and , which controls how fast data belonging to the second branch transition from the basal process to the branch process. Each data point is assigned a branch label, ∈ 1,2 , and observations are a priori Gaussian distributed: } , < | , ( , ( , $ , , ′)), where: , $ , , $ = } , $ + / 0 2 , < ( , ′) ;,< ; = ,< + /,/ = ;,; = , and the delta function ;,< ; = ,< ensures the change--point kernel only operates over the second branch i.e., where the branch label = 2 and ′ = 2. Within this framework, we may again make a prediction * at a new input location, ( * , * ), and analytically evaluate the marginal likelihood, allowing us to compare the goodness of fit between different branching processes. Within our framework, we can allow further branches that independently diverge from the main branch, with an n--component system defined by the following covariance function:
2 ,` ‡( , ′) ;,ˆ; = ,6‰< + /; /$;$ . Finally, each branch itself could give rise to further branching in a recurrent manner e.g., a basal (main branch) from which a secondary branch diverges, with a third branching from the second and so forth. For an n--component recurrent branching system we have: When observation data for all branches are specified over identical time points, the covariance matrix can be expressed in a more compact notation:
where ⨂ denotes the Kronecker product, and:
where represents the number of unique time points, represents an ( × ) identity matrix, and (•) = ⊺ , with representing a column vector of length , with ones in elements through and zeros everywhere else. Far more complex branching patterns can easily be built via the correct composition of independent and recurrent branching covariance functions. As well as building branching structures of arbitrary complexity, we further note that the dynamic behaviour of the individual branches may themselves be arbitrarily complex, comprised of any linear combination of positive semi--definite kernels. In Figure 1 (a) we indicate example behaviour of simple branching GPs. Here we include a heatmap representation of the covariance function evaluated at 1,000 uniformly incremented test locations (leftmost column), and two independently drawn samples from the prior distribution at those test locations (middle and rightmost columns).
Recombinant Gaussian processes
Recombinant processes can be defined in a reciprocal fashion to branching processes. Notable examples might include the reprogramming of different terminally differentiated cell lineages to iPSCs . We can describe a two--component system via the following composition of covariance functions: 
Branch-recombinant Gaussian processes
Another important process exists where a statistical process transiently branches into two or more processes, before recombining back into a single process. Such combinations of branching and recombination may be encountered during development when where there exists more than one route to a terminal cell fate, as may be the case in certain neuronal lineages (Zawadzka et al. 2010) , as well as in certain diseases, such as during dedifferentiation of cancer cells (Friedmann--Morvinski and Verma 2014). An example two--component system can be encoded by the following covariance function: , $ , , $ = } , $ + 3 OE`OE 2 , < ( , $ ) , 2 ;,< ; = ,< + /,/ = ;,; = . Again, more complex patterns, with arbitrary numbers of branches and recombination, can readily be built with GPs via the correct composition of covariance functions, with more complex examples shown in Figure 1(c) .
Limiting behaviour
Depending upon the branch time and other hyperparameters in the change--point kernel, the behaviour of B--RGPs can naturally tend towards either an independent GP or a HGP. Specifically, for a branching GP, when ( ) → 1, as may be the case when (`− )/ is very large, such as when a branch occurs much later than the last data point, then a BGP will behave as single joint GP with behaviour defined by the main branch kernel only. When ( ) → 0, as may be the case when (`− )/ has increasingly low values, such as when branching occurs much earlier than the first observations, then the BGP will behave as a HGP. Similar limiting behaviour applies for recombination processes.
Results
As a preliminary test of the B--RGP framework we fitted four simulated, labelled time series datasets, and evaluated the predictive accuracy over a range of test locations, comparing the accuracy to that achieved using independent Gaussian process regression (IGP) regression over separate branches, or joint Gaussian process regression (JGP) applied to the union of data. In Experiment 1 we evaluated the ability to fit the following branching process: where z indicates the branch label. Three--hundred random input locations were sampled, ~, 3 , with branch labels assigned with equal probability, ˆ∈ [1, 2] . Observations were generated as noisy instances, | ,~( , ), 6 < , where 6 = 0.1. A three--component branching process, comprised of a (latent) main process from which two observed branches diverge, was fitted to the simulated data, with hyperparameters optimised using type II maximum likelihood (ML). Here the base kernel for the main branch was assumed to be a squared--exponential, with the covariance function for the two branches also squared--exponentials. Branching time hyperparameters were tied i.e., • =`OE, with initial values set as `• = 4, log`• ,`OE = 0.5, 6 = 0.2, and all other hyperparameters = [`©,`©,`•,`•,`OE,`OE] initiated as ˆ~0.1,1 . For comparison, IGPs were fitted to the two branches separately using squared--exponential covariance functions, with hyperparameters = [ } , } , < , < ] initialised as ˆ~0.1,1 , and optimised using type II ML estimation.
A JGP with squared--exponential covariance function was also fitted to the union of data, with hyperparameters = [ , ] initialised and optimised as for the independent GPs. In Supplementary Figure 1 (top) we indicate an example posterior GP fit to the data using a BGP, IGPs and JGP respectively. In Supplementary Figure 1 (middle and bottom rows) we indicate the mean sum squared error (SSE) and negative log marginal likelihood over 50 randomly initiated runs. The B--RGP shows increased accuracy (reduced SSE) and decreased negative log marginal likelihood compared to the individual and joint GPs. In Supplementary Figure 1(d) we plot the inferred branch time versus true branch time for 100 instances of a related branching process, in which the branch time is randomly (uniformly) distributed over the interval ∈ (−8, 8). We note that the correlation of R=0.99995 indicates good ability to infer branch times. To explore the ability to infer branch times for datasets with missing observations, we repeated this experiment, but excluded observations close to the true branch point, specifically removing any data points where `− ) < 2, where, ` represents the true branch time, and ) is the time of the data point. Even with missing observations centred at the true branch time, the inferred branch times were found to be highly correlated with the true branch time (R=0.9649; Supplementary  Figure 1(e) ). In Experiment 2 we assumed the following branch--recombinant process: , = 0 if > /2 cos if ≤ /2, = 1 − cos if ≤ /2, = 2 where z indicates the branch label. Again, three--hundred randomly determined input locations were sampled ~0,3 , with branch assignment randomly allocated with equal probability, and observation data generated as | ,~( , ), 6 < , where 6 = 0.1. A three--component branch--recombinant GP, comprised of a (latent) main process from which two branches diverge and recombine, was fitted to the simulated data, with hyperparameters optimised using type II ML estimates. Here the base kernel for the main branch was assumed to be a squared--exponential, with the covariance function for the two branches also assumed to be squared--exponentials. Branching and recombination times for the two branches were tied i.e., `• =`OE and 3 • = 3 OE , with initial values set as `• = −2, 3 • = 1, with log`• ,`OE3 • ,3 OE = 0.5, 6 = 0.2 and all other hyperparameters initiated as ˆ~0.1,1 . For comparison, IGPs and JGPS were also fitted, with hyperparameters initialised as previously described. Results are summarised in Supplementary Figure 2 . To test for robustness to model mismatch, we used B--RGPs on two other datasets. In Experiment 3, a non--branching, three--component process was used to generate data, corresponding to a HGP, 2~0 , 2 , $ , }~2 , } , $ ,
<~2
, < , $ , with squared--exponential covariance functions used throughout. A B--RGP was fitted to the data with hyperparameters initialised as `• = −4, 3 • = 4, log`• ,`OE3 • ,3 OE = 0.5, and log 6 = 0.2, and all other hyperparameters initiated as ~0 .1,1 . In this case, there exists a model mismatch between the data, which has no explicit branching or recombination, and the branch--recombinant covariance function used for inference. Nevertheless, we note that informally, if the branch point occurs much earlier than the first data point and the recombinant point occurs much later than the last data point, the behaviour over the range of observations is identical to that of a HGP, }~0 ,`• , $ +`OE , $ , <~0 ,`• , $ +`¬ , $ . Tuning of the branch/recombination time hyperparameters should therefore allow a good fit over the regions of observation despite the model mismatch. We also considered the explicit limiting case of the B--RGP, with branch/recombination time hyperparameters fixed to arbitrarily low/high values, `• = −40000 3 • = 40000, with all other hyperparmeters initiated and optimised as before. In Supplementary Figure 3(a) we plot example fits to the function using a B--RGP, IGPs and a JGP. In Supplementary Figure 3 (b) we indicate the sum of squared errors for the B--RGP and a limiting case of the B--RGP (denoted with a *) compared to IGPs and a JGP, as well as the negative log marginal likelihoods. As expected, B--RGPs and IGPs were more accurate than JGPs, due to the increased flexibility to fit the two processes, rather than fitting the general underlying trend. In most cases B--RGPs performed comparably to IGPs, although in a few instances the B--RGP appeared to suffer from numerical instability and failed to converge, with the resulting mean SSE and negative log marginal likelihood distributions heavy tailed and not as favourable as for IGPs. The limiting case of the B--RGP was comparable to the IGPs. These results suggest that B--RGPs offer comparable performance to IGPs, although performance depends on sensible initialisation of hyperparameters.
To further evaluate the effect of model mismatch, in Experiment 4 we fit to data from a single, noisy process. Specifically, we used the same three--component HGP as in Experiment 3, with noisy observation data generated from the first process only i.e., representing two replicates }~} ( ), 6 < , <~} ( ), 6 < . As before, we fitted the data using a three--component branch--recombinant process, with squared--exponential covariance function assumed for all branches, and hyperparameters initiated `• = −4, 3 • = 4, with all other hyperparameters initiated identically to Experiment 2. Informally, we note that, despite the model mismatch, when branching and recombination both occur much earlier than the first observation, or much later than the last observation, the fit over the range of observations should correspond to that of a JGP with covariance function corresponding to that of the main branch process, },<~0 , 2 , $ . We therefore chose to include the limiting case, where branch and recombination time hyperparameters were fixed arbitrarily early, `• = −50000 3 • = −40000 with all other hyperparameters initialised and optimised as previously. In Supplementary Figure 3 (c) we indicate example fits to the function using a B--RGP, IGPs and a JGP, whilst in Supplementary Figure 3 (d) we indicate the distribution for the mean SSE and negative log marginal likelihood. In general, both the B--RGP and JGP outperform the IGPs, due to the increased regularisation that can be coded in these models. Both the B--RGP and limiting case of B--RGP offer comparable performance to the JGP. Finally, in experiment 5 we performed inference on a four--branch system, in which we have one latent basal branch, from which two intermediate latent branches emerge. From each of the two intermediate branches we consider two observed branches. For comparison, we evaluate the sum squared error and log marginal likelihood for the B--RGP, IGPs and a JGP, with the results indicating B--RGPs provide better overall performance (Supplementary Figure 4) . From preliminary tests on simulated datasets, we note that the B--RGPs represent efficient and flexible models for describing branching and recombination processes. Crucially, all hyperparameters can be optimised directly using type II ML. Therefore, branch and recombination time hyperparameters can be tuned, which, due to their limiting behaviour, means that they can gracefully cope with datasets where no branching structure exists, provided hyperparameters are sensibly initialised.
Inference for partially labelled datasets
In our previous examples, inference relied on the existence of explicit branch labels. In some cases, however, branch labels may be incomplete or missing entirely. For example, in a collection of single cell transcriptomics data there may be various cell types, including some that cannot be unambiguously assigned to a particular branch a priori. We can attempt to infer the branch labels, z, using Markov chain Monte Carlo (MCMC). Here we assume partially labelled data, with a subset of branch labels know, and the remainder unknown, denoted = [ (labelled) , (unlabelled) ]. When branch labels are known, they can be fixed, whilst unknown branch labels are initialised stochastically, and updated via a Gibbs sampler, similar to the usage in Stegle et al. (2010) . For an n--component branching process, the unknown label for cell , is Gibbs sampled conditional on the observation data and branch assignment of all other cells:
